33 results on '"Ruiz-Heredia, Y"'
Search Results
2. 1176P Potential utility of ctDNA to detect false positive PET/CT in the evaluation of lymphoma response
3. 825P Ultra-sensitive cfDNA analysis for minimally invasive measurable residual disease detection and profiling in multiple myeloma
4. P845: IDENTIFICATION OF MULTIPLE MYELOMA BIOMARKERS VIA LIQUID BIOPSY BASED ON CELL-FREE DNA USING A CAPTURE-HYBRIDIZATION PANEL
5. Characterization of nanoparticulated phases in the manganese oxo/hydroxide system obtained in supercritical water: Optimized conditions for selected compositions
6. A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics
7. Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with ex vivo chemosensitivity
8. PF566 INCREASE OF MITOCHONDRIAL ACTIVITY CONTRIBUTES TO RELAPSE IN MULTIPLE MYELOMA, A NOVEL THERAPEUTIC OPPORTUNITY
9. PF221 MUTATIONAL PROFILE BY NGS COMBINED WITH EX VIVO DRUG SENSITIVITY PROFILE IMPROVE PREDICTION OF AML PATIENT OUTCOME
10. Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma
11. STATES OF RESISTANCE TO TREATMENT IN LMA AND CORRELATION WITH THE FREQUENCY OF ALLELIC VARIANTS DETECTED BY NGS
12. MITOCHONDRIAL ACTIVITY PLAYS A CRITICAL ROLE IN THE RESISTANCE OF MULTIPLE MYELOMA
13. IMPLEMENTATION OF A MULTIPLE MYELOMA SPECIFIC CUSTOM 77-GENE MUTATION PANEL
14. DETECTION OF NEW EMERGING CLONES DURING TREATMENT BY NGS ALLOWS A BETTER RISK PREDICTION ON MULTIPLE MYELOMA PATIENTS
15. FORECAST IMPACT OF THE NUMBER OF COPIES OF MITOCHONDRIAL DNA IN MULTIPLE MYELOMA
16. LOW RPS14 EXPRESSION IN MDS PATIENTS WITHOUT 5Q-ABERRATION SEEMS NOT TO BE RELATED WITH GENOMIC ALTERATIONS IN 5Q REGION
17. APPLICATION OF THE LYMPHOTRACK MASS SEQUENCING KIT (R) IN THE STUDY OF MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA. COMPARISON WITH CMF AND ASO-PCR
18. MRD ANALYSIS BY NEXT-GENERATION SEQUENCING APPROACH FOR ACUTE MYELOID LEUKEMIA FOLLOW-UP
19. Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
20. Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
21. Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
22. Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT.
23. Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase ( PSMC ) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma.
24. Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma.
25. NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial.
26. Cereblon enhancer methylation and IMiD resistance in multiple myeloma.
27. Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma.
28. Pathogenetic and Prognostic Implications of Increased Mitochondrial Content in Multiple Myeloma.
29. Myc-Related Mitochondrial Activity as a Novel Target for Multiple Myeloma.
30. A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics.
31. Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report.
32. A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia.
33. Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.